Profiel
Ross Barrow is currently the Chief Executive Officer and Director at Paranta Biosciences Ltd.
He was previously a Non-Executive Director at Acrux Ltd.
from 2012 to 2015.
Actieve functies van Ross Barrow
| Bedrijven | Functie | Begin |
|---|---|---|
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Algemeen Directeur | - |
Eerdere bekende functies van Ross Barrow
| Bedrijven | Functie | Einde |
|---|---|---|
| ACRUX LIMITED | Directeur/Bestuurslid | 27-02-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACRUX LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Paranta Biosciences Ltd. engages in the research and development of novel biotherapeutic. t develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases. The company was founded in 2011 and is headquartered in Richmond, Australia. | Health Technology |
